Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-931
Closed -$305K 126
2025
Q4
$305K Buy
+931
New +$295K 0.63% 21
2023
Q2
Sell
-1,554
Closed -$376K 63
2023
Q1
$376K Buy
+1,554
New +$381K 0.63% 10
2021
Q2
Sell
-1,471
Closed -$366K 87
2021
Q1
$366K Buy
+1,471
New +$351K 1.18% 20
2014
Q3
$222K Buy
+1,581
New +$206K 0.42% 36

Other funds holding AMGN

Ground Swell Capital's AMGN Position: Q1 2026 in Review

Ground Swell Capital sold out of Amgen (AMGN) in Q1 2026, closing a stake of 931 shares — an estimated $305K sold.

Ground Swell Capital first reported a position in AMGN in Q3 2014 and held it in 4 quarters. The position peaked at $376K in Q1 2023. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ground Swell Capital reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Ground Swell Capital sold 931 Amgen shares in Q1 2026, an estimated $305K.
  • Ground Swell Capital first reported a position in Amgen in Q3 2014 and held it in 4 quarters.
  • Ground Swell Capital's Amgen position peaked at $376K in Q1 2023.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ground Swell Capital's 13F filing for Q1 2026, filed 21 Apr 2026.